Hannah Mitchell

Hannah Mitchell

Auto-generated profile, based on publicly available information

Hannah Mitchell

Mathematical Sciences Research Centre, School Of Mathematics & Physics, Queen's University Belfast, Belfast, UK

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
HNHannah Norman-Bruce
Hannah Norman-Bruce
EUEtimbuk Umana
Etimbuk Umana
CMClare Mills
Clare Mills
LMLisa McFetridge
Lisa McFetridge
HMHannah Mitchell
Hannah Mitchell
TWThomas Waterfield
Thomas Waterfield
Introduction Young febrile infants are at higher risk of invasive bacterial infections (IBIs) compared with older children. The clinical features of IBI are subtle in this cohort mandating that clinicians take a cautious approach to their initial assessment and management. This includes the measurement of blood biomarkers of infection such as C reactive protein (CRP) and procalcitonin (PCT). In the UK, PCT is not widely available and not recommended for routine use in hospital. This is in contrast to Europe and the USA where PCT is regularly used to assist clinical decision-making. The objective of this review and meta-analysis is to report the diagnostic test accuracy of PCT in detecting IBI in febrile infants less than 91 days old, compare its accuracy with CRP and define optimal PCT cut-off values in this cohort. Methods and analysis A search strategy will include MEDLINE, EMBASE, Web of Science, The Cochrane Library and grey literature. There will be no language or date limitations. Diagnostic accuracy studies compliant with STARD criteria will be considered against eligibility criteria. Abstracts, then full texts, of potentially eligible studies will be independently screened for selection. Data extraction and quality assessment, using the QUADAS-2 tool, will be completed by two independent authors and a third author used for any inconsistencies. True positives, false positives, true negatives and false negatives will be pooled to collate specificity and sensitivity with 95% CIs. Results will be portrayed in forest plots, alongside their quality assessments. Ethics and dissemination This review does not require ethical clearance. This review will be published in peer-reviewed journals and key messages will be disseminated through presentations at local and international conferences related to this field. The authors aim for this review to be completed and published in 2023.

6 March 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
DJDaniyal J Jafree
Daniyal J Jafree
CPCharith Perera
Charith Perera
MBMary Ball
Mary Ball
DTDaniele Tolomeo
Daniele Tolomeo
GPGideon Pomeranz
Gideon Pomeranz
DLDavid A Long
David A Long
Hallmarks of autosomal dominant polycystic kidney disease (ADPKD), the most common hereditary kidney anomaly, include expanding fluid-filled epithelial cysts, inflammation, and fibrosis. Despite previous work showing the potential of vascular-based therapies, renal microvascular alterations in ADPKD, and their timing, are poorly understood. Using single-cell transcriptomics of human kidney microvasculature, we identify a population of endothelial cells adjacent to cysts in ADPKD. This pericystic endothelium, distinguishable by its expression of osteopontin (SPP1), has a distinct molecular profile compared to the common endothelial cell injury signature in other kidney diseases. SPP1 + pericystic endothelium was also present in an orthologous mouse model of ADPKD before overt kidney functional decline. By interrogating geometric, topological and fractal properties from three-dimensional imaging of early ADPKD mouse kidneys, we show that pericystic endothelium associates with disorganisation and non-uniformity of the renal cortical microvasculature. Concurrently, we detected region-specific reductions in cortical blood flow within ADPKD murine kidneys using arterial spin labelling. We conclude that ADPKD kidneys contain a unique subset of endothelium manifesting with aberrant remodelling and impaired blood perfusion. Its detection, prior to renal functional decline, advocates the vasculature as a therapeutic target to modulate or preserve renal function in early ADPKD.

3 June 2026 in Journal of Infection
Verified
Journal Article
Open access
CMClare Mills
Clare Mills
HDHolly Drummond
Holly Drummond
NKNarainrit Karuna
Narainrit Karuna
HMHannah Mitchell
Hannah Mitchell
LMLisa McFetridge
Lisa McFetridge
TWThomas Waterfield
Thomas Waterfield
To identify and validate plasma host-response protein biomarkers that improve discrimination of bacterial infection in febrile infants ≤90 days of age, and to assess whether novel biomarkers add value beyond established markers. Sub-study of the prospective multicentre Febrile Infant Diagnostic Assessment and Outcome (FIDO) cohort. Novel biomarkers were identified through plasma proteomic profiling (Olink®) and combined with biomarkers and signatures from the literature for verification using Luminex and ELISA platforms. Diagnostic performance of novel biomarkers, established markers (CRP, PCT), and multi-protein signatures was evaluated. Proteomic profiling of 110 samples identified 174 proteins differentially expressed between bacterial and viral infections, revealing distinct pathogen-specific immune signatures. Verification in the full cohort (n = 445) demonstrated PCT had the highest individual accuracy for invasive bacterial infection (IBI) (AUC 0.89). Combining PCT with novel biomarkers, particularly lipocalin-2 (LCN2), improved discrimination (AUC 0.96). Diagnostic performance for the combined IBI/urinary tract infection (UTI) outcome was consistently lower (AUC <0.8). Febrile infants demonstrate biologically coherent host-response signatures that can be leveraged diagnostically. A PCT-LCN2 combination showed excellent accuracy for identifying IBI and may support future biomarker-guided diagnostic strategies, while reliable discrimination of UTI remains challenging.

28 August 2025 in medRxiv
Verified
Preprint
Open access
PDF file
HNHannah Norman-Bruce
Hannah Norman-Bruce
CMClare Mills
Clare Mills
HDHolly Drummond
Holly Drummond
KLKathy Karman Li
Kathy Karman Li
HMHannah Mitchell
Hannah Mitchell
HGHelen Elizabeth Groves
Helen Elizabeth Groves
Background: Wheezing in the pre-school aged group (under 5 years) is a common presentation and significant healthcare burden. It is a heterogenous presentation representing a spectrum of phenotypes and although the causes may be multifactorial, viral infection is the most common trigger, with rhinovirus and Respiratory Syncytial Virus (RSV) being the most commonly detected. Rigorous evidence-based guidance for the acute management of preschool wheeze (PW) with respect to which children likely to benefit from oral corticosteroid therapy (OCS), is lacking. RCTs of OCS use in PW have not adequately assessed the impact of respiratory virus testing in the management of PW. To address the hypothesis that OCS response may be determined by the specific virus, the feasibility of performing POC respiratory virus tests prior to randomisation in an acute paediatric ED setting needs to be ascertained. Methods: The PRECISE Study will be a single centre, randomised, open-label, feasibility trial. Children aged 24-59 months with acute wheeze will be eligible if the clinician is uncertain if there is a role for oral corticosteroid therapy or not. At enrolment, participants will undergo a nasal swab for rapid respiratory virus testing. Children will be randomised in a 1:1 ratio to receive oral dexamethasone or not, based on their RSV result. Participants will continue to be managed by the clinician according to local guidance. They will be invited for clinical review at 72 hours where a repeat nasal swab may be performed. There will be a telephone follow up at one month and parents will be invited for extended telephone interviews within a further month. Comprehensive screening logs will address the primary outcome of recruitment and timeliness until enrolment. Remaining timeliness and adherence outcomes will be recorded in individual participant records and described using CONSORT diagrams. Acceptability will be measured using a mixed method qualitative approach based on the theory of acceptability framework. Discussion: This pragmatically designed trial will address key feasibility points needed to inform a future, definitive multi-centre RCT prospectively testing the role of respiratory virus testing to randomise children with PW to receive oral corticosteroids or not. Trial registration: NCT06580600 ( clinicaltrials.gov )

18 August 2026 in Statistics in Medicine
Verified
Journal Article
Open access
JHJonathan W. Henderson
Jonathan W. Henderson
BDBenjamin M. Davis
Benjamin M. Davis
HMHannah J. Mitchell
Hannah J. Mitchell
Recent advances in Adaptive‐Optics Confocal Scanning Laser Ophthalmoscopy (AO‐cSLO) have enabled non‐invasive, in‐vivo imaging of retinal cell subsets, at near single‐cell resolution. However, challenges such as spatial and temporal variability, limited observation windows, and segmentation errors hinder the effective use of this data for diagnosing neurodegenerative disorders like glaucoma. Common point pattern metrics used in this area, such as density and distance‐based measures, are sensitive to noise and incomplete data, reducing their diagnostic utility. Fractal measures, with their scale‐invariance and robustness to point pattern degradation, offer a promising alternative. In this study, we apply fractal analysis to RGC point pattern data sets from rodent glaucoma models and controls, comparing fractal dimension, lacunarity, and succolarity with traditional metrics. We find that lacunarity and succolarity provide more accurate and enable earlier detection of glaucoma than traditional metrics, demonstrating greater robustness to noisy and degraded data. These measures demonstrate significant potential for achieving an earlier and more reliable glaucoma diagnosis.